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Our report has limitations. We could not perform 
many blood chemistry tests, in-country virus cultures, or 
deep sequencing on samples. Likewise, diagnosis of coma 
was challenging because of the lack of CSF cell counts, 
biochemistry values, and paired EBOV IgG and IgM titers 
in CSF and blood.
This case raises the practical issue that Ebola treat-
ment requires understanding of multiorgan virologic and 
inflammatory complications; survivor care and research 
programs should screen for neurocognitive impairment and 
consider appropriate imaging. The case confirms previous-
ly reported intermittent EBOV PCR positivity in urine (9). 
The development of arthritis with synovitis, treated with 
corticosteroids, supports the diagnosis of reactive arthritis.
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To the Editor: During the early 20th century, at the 
end of World War I, and during World War II, louseborne 
relapsing fever (LBRF) caused by Borrelia recurrentis was 
a major public health problem, especially in eastern Europe 
and northern Africa (1,2). Currently, poor living conditions, 
famine, war, and refugee camps are major risk factors for 
epidemics of LBRF in resource-poor countries, such as 
those in the Horn of Africa (3,4).
Increased migration from resource-poor countries and 
war/violence create new routes for spread of vectorborne 
diseases. Recently, several cases of LBRF have been re-
ported among asylum seekers from Eritrea in the Nether-
lands, Switzerland, and Germany (5–8). All of these asy-
lum seekers had been in refugee camps in Libya or Italy. 
We report 3 cases of LBRF in migrants from Somalia to 
refugee camps in Sicily, Italy.
Patient 1 was a 13-old-boy from Somalia who arrived 
in Palermo, Italy, on July 11, 2015, after traveling though 
Libya. He was admitted to G. Di Cristina Hospital in Pal-
ermo 5 days after arrival because of high fever, headache, 
and general malaise, which developed 2 days after arrival. 
The patient had skin lesions on his fingers and legs and a 
conjunctival infection. He had thrombocytopenia (79,000 
platelets/μL [reference range 150 platelets/μL–400 plate-
lets/μL]), creatine phosphokinase level 967 mg/L [refer-
ence range 0.001 mg/L–0.10 mg/L], aspartate aminotrans-
ferase level 30 U/L (reference value 37 U/L), and alanine 
aminotransferase level 21 U/L (reference value 41 U/L). 
He was given ceftriaxone (2 g/d) and intravenous hydra-
tion. His conditions worsened ≈10 hours after treatment: 
high fever (temperature 40°C), chills, and profuse sweat-
ing (Jarish-Herxheimer reaction). The patient recovered 
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after 15 days of treatment with ceftriaxone. A Giemsa-
stained blood smear was negative for Plasmodium spp. but 
showed large numbers of spirochetes. Serologic screening 
results for B. burgdorferi were negative.
Patient 2 was a 17-old-boy from Somalia who arrived 
in Lampedusa, Italy, on August 27, 2015, after traveling 
through Libya. Fever and artromyalgia developed 6 days 
after his arrival, and he was admitted to Hospital Paolo Gi-
accone in Palermo. Blood analyses showed increased levels 
of aminotransferases, thrombocytopenia (69,000 platelets/
μL), and mild anemia (hemoglobin level 94 g/L [reference 
range 130 g/L–160 g/L]). A blood smear was negative for 
Plasmodium spp. but positive for spirochetes. Serologic 
screening results were negative for malaria, leptospirosis, 
infection with Rickettsia conorii, and dengue. An ELISA 
result was positive for B. burgdorferi, and a Western blot 
result was positive for Borrelia spp. proteins p10, p41, and 
OspC. The patient recovered after treatment with doxycy-
cline (100 mg/d) and ceftriaxone (2 g/d) for 10 days.
Patient 3 was a 17-year-old boy from Somalia who ar-
rived in Trapani, Italy, on September 4, 2015. He reported 
that he stayed for 5 months in Libya before arriving in Italy. 
Fever, artromyalgia, severe dehydration, renal failure, and 
mental confusion developed 3 days after his arrival, and 
he was admitted to Hospital Paolo Giaccone. He had se-
vere thrombocytopenia (4,000 platelets/μL); mild anemia 
(hemoglobin level 88 g/L); increased levels of aminotrans-
ferases (aspartate aminotransferase 282 U/L, alanine ami-
notransferase 489 U/L), lactate dehydrogenase (1,041 U/L 
[reference range 105 U/L–333 U/L]), d-dimer (6,311 ng/
mL [reference range 10 ng/mL–250 ng/mL]), C-reactive 
protein (237.8 mg/dL [reference range 0 mg/dL–10 mg/
dL]), and creatinine (2.6 mg/dL [reference range 0.6 mg/
dL–1.2 mg/dL]); and azotemia (blood urea nitrogen level 
150 mg/dL [reference range 7 mg/dL–20 mg/dL]). A blood 
smear was negative for Plasmodium spp., but a Giemsa-
stained thick blood smear was positive for spirochetes. 
Serologic screening results were negative for malaria, lep-
tospirosis, infection with B. burgdorferi, and dengue. The 
patient recovered after treatment with doxycycline (100 
mg/d) and ceftriaxone (2 g/d) for 10 days.
DNA was extracted from blood specimens from the 
3 patients and used for molecular identification and char-
acterization of the etiologic agent of LBRF. We used a 
species-specific real-time PCR for B. recurrentis and B. 
duttonii, which targeted an internal region of the recN 
gene. Multispacer sequence typing of the 16S rRNA 
gene was used for bacterial identification and genotyping 
(9,10). All blood samples were positive for B. recurrentis 
by real-time PCR. Multispacer sequences showed 100% 
identity with sequences of B. recurrentis reference strain 
A1 (GenBank accession no. CP000993) for isolates from 
all patients.
We report 3 patients in Italy with LBRF who migrated 
from Somalia. These patients arrived in Italy after traveling 
in several countries in Africa and crossing the Mediterra-
nean Sea. The patients did not associate with each other 
during travel, and the place where they were infected is 
unknown. However, because they came from a disease-en-
demic country, they probably had been infested with body 
lice and were infected with B. recurrentis in Somalia or 
other neighboring countries.
Because the 3 cases we observed might indicate that 
more migrants and refugees are infected, LBRF should be 
considered an emerging disease among migrants and refu-
gees. Diagnostic suspicion of LBRF should lead to early 
diagnosis among refugees from the Horn of Africa and in 
persons in migrant camps. Furthermore, improved public 
health measures and hygiene must be implemented for per-
sons in refugee or migrant camps.
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